Scilex Holding (SCLX) Cash & Equivalents (QoQ) (2020 - 2026)

Scilex Holding (SCLX) Cash & Equivalents (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,162,528.78 Bn 93,162,523.82 Bn 7.76 Bn
2 Eli Lilly 1,017.87 Bn 1,012.58 Bn 16.22 Bn
3 Johnson & Johnson 575.51 Bn 553.46 Bn 15.96 Bn
4 AbbVie 400.43 Bn 391.08 Bn 10.78 Bn
5 Merck 294.19 Bn 288.54 Bn 12.09 Bn
6 Amgen 182.41 Bn 170.37 Bn 5.87 Bn
7 Gilead Sciences 150.97 Bn 143.24 Bn 5.52 Bn
8 Pfizer 145.75 Bn 132.97 Bn -1.21 Bn
9 Bristol Myers Squibb 113.35 Bn 102.90 Bn 8.07 Bn
10 Scilex Holding 57.99 Mn -91.94 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2,823.77%
Dec 31, 2025 450.56%
Sep 30, 2025 -78.05%
Jun 30, 2025 -29.31%
Mar 31, 2025 77.26%
Dec 31, 2024 4,149.35%
Sep 30, 2024 -98.88%
Jun 30, 2024 278.88%
Mar 31, 2024 -53.63%
Dec 31, 2023 96.05%
Sep 30, 2023 -94.14%
Jun 30, 2023 569.06%
Mar 31, 2023 133.52%
Dec 31, 2022 6,146.96%
Sep 30, 2022 -90.05%
Jun 30, 2022 175.64%
Mar 31, 2022 -97.06%
Dec 31, 2021 3,651.23%
Sep 30, 2021 -55.11%
Jun 30, 2021 -18.19%